Evidence map›Paper›PMID 38649419›Full record

ArticleCancer gene therapy2024

miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39.

Lu Wang, Huijuan Liu, Qinglu Wu, Yiqian Liu, Zhenpeng Yan, Guohui Chen, Yao Shang, Songrui Xu, Qichao Zhou, Ting Yan and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lu WangTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Huijuan LiuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Qinglu WuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Yiqian LiuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Zhenpeng YanTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Guohui ChenTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Yao ShangTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Songrui XuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Qichao ZhouTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Ting YanTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. enntei@hotmail.com.
Xiaolong ChengTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. chengxl@sxmu.edu.cn.ORCID 0000-0001-8726-5631
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are emerging mediators of cell-cell communication, which are secreted from cells and may be delivered into recipient cells in cell biological processes. Here, we examined microRNA (miRNA) expression in esophageal squamous cell carcinoma (ESCC) cells. We performed miRNA sequencing in exosomes and cells of KYSE150 and KYSE450 cell lines. Among these differentially expressed miRNAs, 20 of the miRNAs were detected in cells and exosomes. A heat map indicated that the level of miR-451a was higher in exosomes than in ESCC cells. Furthermore, miRNA pull-down assays and combined exosomes proteomic data showed that miR-451a interacts with YWHAE. Over-expression of YWHAE leads to miR-451a accumulation in the exosomes instead of the donor cells. We found that miR-451a was sorted into exosomes. However, the biological function of miR-451a remains unclear in ESCC. Here, Dual-luciferase reporter assay was conducted and it was proved that CAB39 is a target gene of miR-451a. Moreover, CAB39 is related to TGF-β1 from RNA-sequencing data of 155 paired of ESCC tissues and the matched tissues. Western Blot and qPCR revealed that CAB39 and TGF-β1 were positively correlated in ESCC. Over-expression of CAB39 were cocultured with PBMCs from the blood from healthy donors. Flow cytometry assays showed that apoptotic cells were significantly reduced after CAB39 over-expression and significantly increased after treated with TGF-β1 inhibitors. Thus, our data indicate that CAB39 weakens antitumor immunity through TGF-β1 in ESCC. In summary, YWHAE selectively sorted miR-451a into exosomes and it can weaken antitumor immunity promotes tumor progression through CAB39.

Indexed as

Disease ProgressionEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaExosomesMicroRNAs14-3-3 ProteinsAnimalsApoptosisCalcium-Binding ProteinsCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMice14-3-3 ProteinsCAB39 protein, humanCalcium-Binding ProteinsMicroRNAsMIRN451 microRNA, humanYWHAE protein, human

Identifiers

PMID38649419
OpenAlexW4394999854

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.